Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome

Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome

Source: 
BioSpace
snippet: 

Life sciences venture capital firm Flagship Pioneering launched its latest company on Tuesday. Prologue Medicines debuts with $50 million in Flagship dollars to mine the ever-expanding set of virus proteins for drug candidates.